Pharma and Biotech
By Sean Farrell
Date: Thursday 15 Jul 2021
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
By Sean Farrell
Date: Wednesday 10 Feb 2021
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
By Josh White
Date: Thursday 18 Jul 2019
(Sharecast News) - Nuformix reported total revenue of £0.61m in its final results on Thursday, rising from £0.02m in the prior year, with the company swinging to a gross profit of £0.07m, from a loss of £0.19m.
Currency | UK Pounds |
Share Price | 0.098p |
Change Today | 0.008p |
% Change | -7.14 % |
52 Week High | 0.20 |
52 Week Low | 0.048 |
Volume | 27,833,433 |
Shares Issued | 1,995.71m |
Market Cap | £1.95m |
Beta | 0.08 |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:23 | 56,817 @ 0.096p |
15:39 | 541,290 @ 0.100p |
15:22 | 1,000,000 @ 0.100p |
15:06 | 5,070,561 @ 0.096p |
12:56 | 886,456 @ 0.100p |
You are here: research